European Graves’ disease market is growing at a CAGR of around 4.4% during the forecast period. Europe consists of numerous key economies including the UK, Germany, Spain, Italy, and Russia among various others which play a significant role in the development of the Grave’s market in the region. The key reason which is promoting the growth of the market in Europe is the changing lifestyle and higher prevalence of smoking in the countries of European region is expected to promote the prevalence of Grave’s disease, thereby creating opportunity for the growth of the European Graves’ diseases market over the forecast period.
To Request a Sample of our Report on European Graves’ disease Market: https://www.omrglobal.com/request-sample/european-graves-disease-market
Europe is the well-established region comprises of few of the largest economies of the world. The region has established healthcare industry due to growing funding in the healthcare R&D and awareness programs. This directly impacts the funding and awareness about thyroid related diseases such as Grave’s disease, thyroid cancer and others. Presence of the key market players such as Apitope technology Ltd., GlaxoSmithKline PLC and others is also affecting the growth of the market. Growing prevalence of type-1 diabetes is one of the major factors contributing significantly in the European Grave’s disease market.
Further, Apitope International NV is a biotechnology company, based in Belgium, that manufactures and markets commercialized products for autoimmune disease. The company provides product candidate ATX-GD-59 that is a disease-modifying treatment for Grave’s disease. ATX-GD-59 is presently being assessed in a Phase I study in patients and the company plans to initiate a Phase II study in the first quarter of 2019. Thus, the presence of the market players strengthens the domestic presence and also aids in the growth of the European Graves’ disease market.
(Get 15% Discount on Buying this Report)
A full Report of European Graves’ disease Market is Available @ https://www.omrglobal.com/industry-reports/european-graves-disease-market
European Graves’ disease Market Segmentation
By Diagnosis
- Ultrasound
- Imaging Tests
- Radioactive Iodine Uptake
- Blood Sample
By Treatment
- Anti- Thyroid Medication
- Radioactive Iodine Therapy
- Surgery
Regional Analysis
- UK
- Germany
- France
- Italy
- Spain
Rest of Europe
Company Profiles
- Abbott Laboratories Inc.
- Allergan PLC
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Macleods Pharmaceuticals Ltd.
- Merck & Co. Inc
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
